RE:Razor thin balance sheetIt's easy to justify raises at higher levels under the auspices of Billionairez especially when we're all 'blinded by science'. It was never much of a problem but post short critique it's proven to be a trainwreck which has left The Science vulnerable, now the last crutch to break. What's next for PLI if we don't get timely approval from the FDA?
HighteawithIntrepid wrote: Come on believers our balance sheet should have been PL's
primary concern. The first rule is raise or borrow money when
you don't need it not when you do. I truly wish I was a short as I
would be up money but unfortunately Pea and I are angry conscripts
that feel PLI failed to disclose the actual wait time. 95% of us were
counting down the days to June 5. Every lost penny since then rests
with PL. Just remember no positive posts equals no posts from me.
Think of yourselves as White chess pieces and the negative posters
as black pieces. You move we respond. Oh and the constant share price
news is a white move.